Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosisAlberto Gajofatto, Emmanuelle Waubant, Peter Bacchetti et al.|Multiple Sclerosis Journal|2008Cited by 98